In contrast, TP53 was predicted to be a negative regulator of the T cell receptor signaling pathway [30], cytosolic DNA-sensing pathway and RIG-I-like receptor signal pathway in GBM, and/or LUSC (Figure 7). The gene discussed is TP53; the disease is glioblastoma.